Immunolabeling in the TgF344-AD rat brain, a model presenting with largely Ab42 fibrillar deposits, confirmed the enhancement of MMP9 and CCL2, along with the pro-inflammatory PAI-1, MMP12, and C1R in microglia surrounding parenchymal amyloid plaques (Figure 7). This evidence concerns the gene CCL2 and Alzheimer disease.